Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer
about
The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapyCytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisFortifying the Treatment of Prostate Cancer with Physical ActivityVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialComparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer CellsMidkine is a NF-kappaB-inducible gene that supports prostate cancer cell survival.TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanismsExercise-induced biochemical changes and their potential influence on cancer: a scientific reviewProinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells.Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancerA review of the application of inflammatory biomarkers in epidemiologic cancer research.Threonyl-tRNA synthetase overexpression correlates with angiogenic markers and progression of human ovarian cancerPeriprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness.Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosisCancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer.Metabolic imbalance and prostate cancer progression.Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseNatriuretic peptide receptor a as a novel target for prostate cancerPossible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stromaConcise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinomaVitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1.Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistanceThe link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives.Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrolBiomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.Direct Write Protein Patterns for Multiplexed Cytokine Detection from Live Cells Using Electron Beam LithographySignificance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma.Tumor markers in prostate cancer I: blood-based markers.Obesity and prostate cancer: weighing the evidence.Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling
P2860
Q24801373-BA9A4517-954F-4D64-BB04-F07BB6659662Q26741263-65C3B304-BEE0-4E6F-A953-8EBD5FB4875DQ26765503-7E5FEF82-FBE3-4047-964C-F2124E92ED0EQ26768536-AFFD2018-D705-45B2-B282-EBA7B7B9F55EQ27022638-E4678A12-F840-4636-9D11-03462F0AC53FQ28553202-29E75E54-51E8-4D30-806C-28A6A37753CBQ33319901-E9EC8329-1DA3-4971-8B24-B2A2C2026E89Q33747708-A361767A-E49E-45A8-AEB1-1EE38DD09C5BQ33785535-60FE83BF-2652-4EA2-B7C2-F017F9465764Q33813680-F29EFBD1-2078-4702-85C7-400505435BA9Q33854379-775A7A39-213A-4D07-91B5-1CBE0BE3CC9AQ34135803-109D6161-A596-466E-A194-4F446A7AAC19Q34135915-CAFA5AEA-0D5F-4C08-B6A7-CC139A7D7A2FQ34255328-4B814807-B4F6-42F0-B462-3DE59B50F351Q34566295-723DDADF-F785-4014-ADB4-FB903CCC362DQ34697129-39A59294-74C4-4524-B68D-1A23B7A8C388Q34794028-03AFE24A-1577-4BA2-BD74-19C3FE25CC22Q34894332-C1ABCA3C-C149-490B-8FA5-9F5047791A9AQ34917061-4990D0C3-61EB-4E58-810A-4DCED68FBBC9Q35064001-225BB04E-2E29-446A-BF93-A23E8B76E118Q35088166-21473D5B-F905-4782-AF57-2C7498D423BEQ35111874-C3AFDD8A-4FF1-4D13-9181-87C731590C2CQ35302321-0C698F0C-DD45-49FD-8431-B561B0D758E9Q35322827-6B131CDF-7342-46A4-ABAB-C9D6932C1456Q35620992-787E362F-EE87-4E1D-A6F4-7D77B571EC12Q35873154-80990AC5-DBE4-4246-AA01-CB7A6773FD97Q35911497-4E87ADE9-B85D-42F4-B191-D8C49FC87956Q36011499-8EEA07E2-4BDC-4EE2-BC8E-D461B5FACEB4Q36052673-AB7E06F2-4A8C-46B4-9BC0-E895501AC06FQ36282200-2997F08B-3082-4FE2-BCE9-91BBBEB6C9E5Q36339823-91C0C9FC-2AB2-4A61-A66F-C66D45A1B01DQ36361936-7B932112-131B-4F3A-91DE-89BDDFCD9330Q36407003-A654F628-7A28-4E64-8AEB-F906DCD3A25CQ36510251-1194917C-CF78-4693-870D-9225DD5A763AQ36532342-E91F9659-FA25-4B83-BF14-04F98313FB09Q36607766-25D7C190-5FDD-48A6-BF53-232DB1935DF1Q36685022-E8C1D0C0-A9F9-4A00-BC5D-B01C535CDB31Q36693094-2D4803DA-5909-4D84-AAFB-8871912CAA11Q36693206-C875D35C-A2B5-487F-9737-BD23CD49CB1CQ36879620-AC42BFB8-DA2B-4245-9415-5AC700D0C2F7
P2860
Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Serum levels of IL-6 and TNF-a ...... patients with prostate cancer
@en
type
label
Serum levels of IL-6 and TNF-a ...... patients with prostate cancer
@en
prefLabel
Serum levels of IL-6 and TNF-a ...... patients with prostate cancer
@en
P2093
P2860
P356
P1476
Serum levels of IL-6 and TNF-a ...... patients with prostate cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601814
P407
P577
2004-06-01T00:00:00Z
P5875
P6179
1046963899